Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Top-Ranked Sector ETFs To Buy For Q3

Published 06/27/2018, 12:15 AM
Updated 07/09/2023, 06:31 AM
US500
-
DJI
-
VG
-
RGI
-

As we are on the verge of stepping into the third quarter of 2018, investors may be interested to in knowing which sectors can perform well ahead. This is especially true given that investors are caught in the crossfire of trade tensions and political crisis in Europe. An economic slowdown in developed economies and emerging market selloffs are added tensions.

So, it would be intriguing to note some sector ETFs that have a Zacks Rank #1 (Strong Buy) and 2 (Buy) and are likely to outperform ahead.

Technology

Tech stocks were hit hard in mid-March but rebounded nicely in Q2, having survived nearly a one-month rout. The sector has been on stronger ground. Rising enterprise spending, the tailwind of tax cuts and emerging technologies like cloud computing, artificial intelligence and big data are the wind beneath the wings of the tech sector (see all technology ETFs here).

Investors should note that tech behemoths hoard huge cash overseas and are poised to benefit the most from Trump's repatriation tax policy. Also, investors can expect higher dividend distribution or share buyback from this move.

Invesco Dynamic Networking ETF (PXQ), Vanguard Information Technology ETF (NYSE:VG) T) and First Trust Dow Jones Internet ETF FDN are some of the top-ranked ETFs that could be targeted now.

Industrials

The industrials sector is supposedly one of the key beneficiaries of the Trump administration thanks to his infrastructure plan that should create higher demand for a wide range of manufacturing products. Also, the tax reform could accelerate depreciation (as indicated by research firm Fundstrat), which in turn would boost capital spending and a lead to step-up in the sector’s activity.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

However, since import tariffs are now creating an upheaval, investors can rely on Zacks Rank #2 fund PSCI, which has a focus on small domestically focused industrial companies.

However, some large-cap funds also have favorable ranks. These are the likes of Guggenheim S&P 500 Equal Weight Industrials ETF (AX:RGI) , Fidelity MSCI Industrials Index ETF FIDU and First Trust RBA American Industrial Renaissance ETF AIRR.

Consumer Discretionary

A raft of upbeat economic data and a solid U.S. market reignited optimism in the consumer discretionary space. With OPEC planning to boost output in the coming days, we can expect a moderation in the oil price rally (read: Best Sector ETFs of Last Week).

A pickup in the economy is great for a cyclical sector like consumer discretionary or retail. Such sectors perform better in a rising rate environment that we are witnessing currently in the United States (read: Here's Why the Rally in Retail ETFs Will Continue in 2H).

Invesco S&P SmallCap Consumer Discretionary ETF PSCD, SPDR S&P Retail (MX:XRT) ETF XRT and Fidelity MSCI Consumer Discretionary Index ETF FDIS can thus be exercised now.

Financials

A hawkish Fed and the resultant rise in benchmark Treasury yields should favor financial stocks as these perform well in a rising rate environment. Plus, deregulations in the banking industry and overall economic growth are the other positives. SPDR S&P Regional Banking (MX:KRE) ETF (CO:KRE) , Financial Select Sector SPDR ETF (NYSE:XLF) XLF and SPDR S&P Bank (MX:KBE) ETF KBE should thus be followed.

HealthCare

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The sector has been enjoying a host of tailwinds. President Trump’s announcement of the drug plans in May, which were in the best interest of pharma companies, favored the space. The drug plans will likely put pressure on U.S. trading partners, forcing them to pay more for medicines (read: Play the Best Sector of Summer With These ETFs & Stocks).

Also, on May 30, the President signed the 'Right To Try' bill into law. This law will help patients suffering from terminal diseases to undergo experimental treatments and use drugs that are not yet approved by the FDA. Needless to say, the law should bring more opportunities for biotech companies. The U.S. healthcare supply chain is consolidating fast, with deals across the industry ranging from insurers, pharmacies to drug distributors.

iShares US Medical Devices ETF (MT:IHI) , Invesco S&P SmallCap Health Care ETF PSCH and VanEck Vectors Biotech ETF (LON:BBH) are some of the top-ranked ETFs to buy now (read: 5 ETF Ways to Trade 6-Year High U.S. Inflation).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



Vonage Holdings Corp. (VG): Free Stock Analysis Report

SPDR-KBW BANK (KBE): ETF Research Reports

SPDR-FINL SELS (XLF): ETF Research Reports

SPDR-SP RET ETF (XRT): ETF Research Reports

FT-DJ INTRNT IX (FDN): ETF Research Reports

SPDR-KBW REG BK (KRE): ETF Research Reports
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


FID-INDUSTL (FIDU): ETF Research Reports

PWRSH-SP SC C D (PSCD): ETF Research Reports

ISHARS-US MED D (IHI): ETF Research Reports

FT-RBA AMER IND (AIRR): ETF Research Reports

GUGG-SP5 EW IND (RGI): ETF Research Reports

VANECK-BIOTECH (BBH): ETF Research Reports

FID-CON DIS (FDIS): ETF Research Reports

PWRSH-DYN NTWRK (PXQ): ETF Research Reports

PWRSH-SP SC HCP (PSCH): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.